Trends in the $6 Billion Botanical Drugs Industry, 2030: An Assessment of Emerging Growth Opportunities and Strategic Developments
November 20, 2024 11:12 ET
|
Research and Markets
Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Botanical Drug Market by Type, Source, Therapeutic Application, Formulation, End User, Route Of Administration - Global Forecast 2025-2030" report has...
Global Botanical and Plant-Derived Drugs Market (2022 to 2026) - Featuring Bayer, GlaxoSmithKline and Merck Among Others
April 19, 2022 08:33 ET
|
Research and Markets
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "Global Botanical and Plant-Derived Drugs Market 2022-2026" report has been added to ResearchAndMarkets.com's offering. The publisher has been...
Groupe Santé Devonian fournit une mise à jour sur son placement privé préalablement annoncé
August 06, 2018 16:00 ET
|
Groupe Santé Devonian Inc.
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 06 août 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX...
Devonian Health Group provides an update on its previously announced private placement
August 06, 2018 16:00 ET
|
Devonian Health Group Inc.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. QUEBEC CITY, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (“Devonian” or the “Corporation”)...
Groupe Santé Devonian annonce un financement privé, sans syndicat de courtiers, de débentures convertibles
July 19, 2018 08:45 ET
|
Groupe Santé Devonian Inc.
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS Aspri Pharma Canada Inc. agit en tant que souscripteur principalDébentures convertibles non garanties convertibles au...
Devonian Health Group announces Non-Brokered Financing by way of a private placement of Convertible Debenture
July 19, 2018 08:45 ET
|
Devonian Health Group Inc.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. Aspri Pharma Canada Inc. acts as lead subscriberUnsecured Convertible Debentures convertible at a price of...
Groupe Santé Devonian rapporte ses premiers revenus : Résultats Financiers clés pour le trimestre terminé le 30 avril 2018
July 18, 2018 08:45 ET
|
Groupe Santé Devonian Inc.
QUÉBEC, 18 juill. 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD), une société pharmaceutique botanique en stade avancé de...
Devonian Healthcare Group Reports its First ever Revenues: Key Financial Results for Quarter Ended April 30th, 2018
July 18, 2018 08:45 ET
|
Devonian Health Group Inc.
QUEBEC CITY, July 18, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSX VENTURE:GSD), a clinical stage botanical pharmaceutical corporation focused on...
Devonian annonce l’octroi d’options
June 29, 2018 08:45 ET
|
Groupe Santé Devonian Inc.
QUÉBEC, 29 juin 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonce que le conseil d'administration a approuvé l'octroi d'options...
Devonian Announces Grant of Options
June 29, 2018 08:45 ET
|
Devonian Health Group Inc.
QUEBEC CITY, June 29, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSX VENTURE:GSD) announces that the Board of Directors has approved the grant of options...